Page 1 of Clinical Trials for myeloma, 1510 Total Matches
- 1RecruitingLast Updated: January 27, 2012Condition(s): Multiple Myeloma
- 2Active, not recruitingLast Updated: May 4, 2012Condition(s): Multiple Myeloma
- 3RecruitingLast Updated: March 19, 2012Condition(s): Multiple Myeloma
- 4RecruitingLast Updated: April 16, 2012Condition(s): Multiple Myeloma
- 5RecruitingLast Updated: May 1, 2012Condition(s): Multiple Myeloma
- 6RecruitingLast Updated: January 30, 2012Condition(s): Cancer; Myeloma; Multiple Myeloma
- 7RecruitingLast Updated: December 21, 2011Condition(s): Multiple Myeloma
- 8SuspendedLast Updated: November 1, 2011Condition(s): Multiple Myeloma and Plasma Cell Neoplasm
- 9Active, not recruitingLast Updated: April 26, 2012Condition(s): Monoclonal Gammopathy of Undetermined Significance; Multiple Myeloma; Plasma Cell Neoplasm
- 10RecruitingLast Updated: August 5, 2011Condition(s): Multiple Myeloma and Plasma Cell Neoplasm; Renal Failure
- 11RecruitingAllogeneic GM-CSF Vaccine and Lenalidomide in Treating Myeloma Patients With Near Complete RemissionLast Updated: March 7, 2012Condition(s): Multiple Myeloma
- 12RecruitingLast Updated: April 18, 2012Condition(s): Multiple Myeloma
- 13Active, not recruitingLast Updated: April 29, 2009Condition(s): Refractory Multiple Myeloma; Relapsed Multiple Myeloma; Multiple Myeloma
- 14RecruitingLast Updated: December 5, 2011Condition(s): Multiple Myeloma
- 15CompletedLast Updated: December 26, 2008Condition(s): Multiple Myeloma
- 16Not yet recruitingLast Updated: May 9, 2009Condition(s): Multiple Myeloma and Plasma Cell Neoplasm
- 17Active, not recruitingLast Updated: August 17, 2011Condition(s): Multiple Myeloma
- 18RecruitingLast Updated: January 23, 2012Condition(s): Multiple Myeloma; Relapsed Multiple Myeloma; Refractory Multiple Myeloma
- 19CompletedLast Updated: September 21, 2007Condition(s): Graft vs Host Disease; Multiple Myeloma
- 20RecruitingLast Updated: March 28, 2012Condition(s): Multiple Myeloma
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=myeloma
